{"database": "lobbying", "table": "lobbying_activities", "rows": [[3184563, "b802b3d8-9f3a-4bb5-afb8-188872da3d83", "Q2", "KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)", 401105192, "CVS HEALTH", 2024, "second_quarter", "HCR", "Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-06-28T09:00:35-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3184563"], "units": {}, "query_ms": 0.27468311600387096, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}